Asset Dedication’s Principia Biopharma PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-9
Closed -$1K – 837
2020
Q3
$1K Hold
9
– – ﹤0.01% 746
2020
Q2
$1K Hold
9
– – ﹤0.01% 633
2020
Q1
$1K Hold
9
– – ﹤0.01% 634
2019
Q4
$0 Hold
9
– – ﹤0.01% 825
2019
Q3
$0 Buy
+9
New +$330 ﹤0.01% 647

Asset Dedication's PRNB Position: Q4 2020 in Review

Asset Dedication sold out of Principia Biopharma (PRNB) in Q4 2020, closing a stake of 9 shares — an estimated $1K sold.

Asset Dedication first reported a position in PRNB in Q3 2019 and held it in 5 quarters. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold PRNB as of Q4 2020.

  • Asset Dedication reported no remaining Principia Biopharma position as of Q4 2020 after selling out during the quarter.
  • Asset Dedication sold 9 Principia Biopharma shares in Q4 2020, an estimated $1K.
  • Asset Dedication first reported a position in Principia Biopharma in Q3 2019 and held it in 5 quarters.
  • Asset Dedication's Principia Biopharma position peaked at $1K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Principia Biopharma as of Q4 2020.

Based on Asset Dedication's 13F filing for Q4 2020, filed 28 Jan 2021.